1-5 To improve functional status among patients with HF, research began to explore ID as a potential clinical target over 20 years ago. 6-11 Since then, a breadth of randomized clinical trials and ...

A gene therapy for heart failure being developed by Bayer’s AskBio unit has been granted fast-track status by the FDA, shortly after it showed preliminary signs of efficacy in a phase 1 trial.

In the RESHAPE-HF2 trial, 505 patients with systolic HF (left ventricular ejection fraction 20-50% and New York Heart Association [NYHA] class II-IV HF symptoms) and moderate to severe functional MR ...

Berlin: Bayer has announced the submission of marketing authorization applications to the U.S. Food and Drug Administration ...

Background Heart failure (HF) guidelines recommend routine testing for iron deficiency (ID) and, for those with ID, ...

Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Testing for natriuretic peptide markers, such as B-type natriuretic peptide (BNP) or N-terminal proBNP (NT-proBNP), has ...

Initiation or switching β blockers is not recommended in patients experiencing a severe decompensation of HF (e.g., requiring ... improved in terms of LVEF and NYHA class. Patients were switched ...

Preventive medicine is a type of medical treatment focused on disease prevention. This strategy could be particularly useful to treat individuals with risk factors for a disease. Strategies used ...

One potential symptom of congestive heart failure is a cardiac cough. This may occur because of fluid building up in the lungs, and it may be a sign that the condition is worsening. Share on ...

Compared to the previous draft class, which had some shaky starts to their first couple of years in East Rutherford, Schoen’s latest core has been a rare positive for the Giants’ miserable season.